Acute thrombosis of cerebral veins and sinuses (ATCVS) is a multifactorial disease with grave consequences. Because of its rare occurrence there are no proven treatment guidelines. Sixteen patients with ATCVS were treated. The final diagnosis was confirmed by digital subtraction angiography. Sinus catheterization was performed via transfemoral venous access. Treatment included mechanical manipulation of thrombi and thrombolytic therapy. A regression of clinical symptoms with a concomitant decrease of intracranial hypertension was achieved in all patients. Long-term results were studied in eight patients: none presented clinical signs of intracranial hypertension. Endovascular transvenous recanalization is an effective treatment for acute thrombosis of cerebral veins and sinuses. Along with the local thrombolysis, significant potential in the treatment of this complex pathology lies in the transvenous endovascular techniques of mechanical thrombus extraction, especially in patients with intracranial hemorrhage for whom the use of thrombolytic agents is restricted.
Introduction
The first description of cerebral venous and sinus thrombosis is attributed to the French doctor Ribes, who in 1825 discovered the thrombosis of the superior sagittal sinus and cerebral veins at autopsy in a man who had suffered severe headaches and seizures for six months 1 . Up until the second half of the 20 th century, thrombosis of cerebral veins and sinuses was usually found at autopsy 2 . In the early 1950s, the introduction of venography made it possible to diagnose thrombosis with greater accuracy and differentiate it from idiopathic intracranial hypertension 3 . The British gynecologist Stansfield is credited with the implementation of anticoagulant heparin in the treatment of cerebral venous and sinus thrombosis in 1942 2, 4 .
The incidence of thrombosis of cerebral veins and sinuses is 1000 times lower than that of arterial strokes 5 , and it is generally a disease of young adults and children 6 . According to the literature 7, 8 , ATCVS is observed in three to four cases per one million population; 75% of these patients are women of reproductive age (20 to 35 years) who also have various congenital coagulopathies. Unilateral infarctions are extremely rare 9 . The incidence of thrombosis in children is up to seven cases per one million population. Every eighth patient subsequently develops severe disability. Mortality varies from 10% to 50%. However, with the timely implementation of appropriate treatment, recovery occurs in more than 80% of patients 6, [10] [11] [12] [13] [14] .
The clinical symptoms of ATCVS vary widely and the course of disease is highly individual for each patient. The determining factors are: location and spread of the process, patient's age, degree of development of venous collaterals of the brain, as well as the primary cause of blood clots in the venous system of the brain. The following symptoms are most frequent: severe headaches, intracranial hypertension, paresis and paralysis of cranial nerves, seizures, motor and sensory disturbances in the extremities, and impaired consciousness to varying degrees. The underlying pathogenetic Guide catheter 6F was installed in the internal jugular vein, in some cases it was inserted in the sigmoid or transverse sinuses. For sinus catheterization Excelsior SL-10 (Boston Scientific) or Prowler 14 (Codman) microcatheters were used. With the help of a microguidewire the catheter was threaded through the thrombus and superselective sinusography was performed. Next, the tip of the microcatheter was placed directly into the thrombi, and before administration of drugs, the thrombi were mechanically manipulated with a micro guidewire. The following thrombolytic agents were used: actilyse (rtPA), prourokinase, and urokinase. Throughout the procedure, heparin was administered at a dose of 5,000 units/hour (on average 7500 units were given per procedure). After the procedure, introducers were sutured to the skin of the thigh, and were removed the next day. Hemostasis was carried out in most cases by local compression of soft tissues in the puncture site. In two cases the femoral artery puncture sites were sealed with suturing devices.
After endovascular treatment the patients received heparin 5000U four times a day or Clexane (enoxoparin) 40-80 mg/day during two weeks, monitoring coagulation, then Plavix (clopidogrel) 300 mg/day during two weeks with the transition to Aspirin 75 mg/day for one year.
Results and Discussion
Clinical symptoms in patients with ATCVS are shown in Table 1 . In addition to a pronounced cephalgic syndrome, all patients had various degrees of papilledema. Severe cerebral and intracranial hypertension symptoms with the confirmed diagnosis of ATCVS according to CT or MR angiography was considered an indication for endovascular intervention. Most of the interventions were performed on an emergency basis on the day of the admission.
According to cerebral contrast angiography, isolated total or partial thrombosis of the superior sagittal sinus (SSS) was established in five patients. The combination of SSS and the involvement of one of the lateral or transverse sinuses was found in seven patients, an isolated occlusion of the lateral sinus (LS) -in one patient, SSS and both LS -in 2 patients, occlusion of the SSS, LS and straight sinus -in one patient. The involvement of the lateral sinus was observed more frequently on the right side (seven patients) than the left (two patients). By means of angiography, the localization and mechanism of the disease is the difficulty of venous outflow from the brain tissue caused by an obstruction of a major drainage pathway. This factor leads to the development of venous intracranial hypertension, cerebral edema, and as a consequence, CSF hypertension. The ventricles of the brain usually stay at normal size, or become slit-like. In the most severe cases, ischemic and/or hemorrhagic lesions may develop in the brain tissue.
The rare occurrence of ATCVS and little experience in treating this disease do not allow for a statistically valid study that would evaluate the effectiveness of a method of treatment. Hence, there are no proven treatment guidelines. However, according to a retrospective review, the mortality rate for patients treated with either IV heparin or local thrombolytics was 13% compared with 48% in untreated patients 12 and local thrombolysis has better follow-up results in severe cases 15 .
Materials and Methods
During the period from 2005 to 2012, the N.N. Burdenko Neurosurgery Institute examined and treated 16 patients with ATCVS: four males, 12 female, aged from six to 51 years. Disease duration from the first symptoms was 4-27 days ( Table 1) .
Etiological risk factors were: oral contraceptives -three patients, pregnancy -one, pregnancy with associated thrombophilia -one, hormone replacement therapy for endocrine disorders -two, thrombophilia -one, chemotherapy for blood disorders -two, anemiaone, antiphospholipid syndrome -one, direct surgery of parasagittal meningioma -one. In three cases the cause could not be established. All patients were admitted with emergency indications (Table 1) . After treatment, all patients were consulted by a hematologist and had a full work-up to identify blood clotting disorders. Thus, in some patients etiologic factors were verified retrospectively.
Primary diagnosis was established on the basis of CT, MR venography, and transcranial Doppler. The rate of blood flow in the straight sinus ranged from 40 to 120 cm/s 16 Figure 2 ). According to the control angiography immediately after thrombolysis, complete or partial recanalization of the sinuses was achieved in all patients. Rethrombosis occurred in two patients two days after the procedure. One of them required a second procedure, the other had a single intravenous administration of the maximal therapeutic dose of a thrombolytic drug. In both cases complete recanalization was achieved. Immediately after the intervention, patients reported a significant reduction or disappearance of the cephalgic syndrome. Most of the time the existing focal symptoms tended to regress on the next day. Ultimately, all patients achieved regression of clinical symptoms with a simultaneous decrease of intracranial extent of thrombosis were identified and the extent of the venous outflow from the cranial cavity was calculated by measuring the transit time of contrast material, ranging from 16 to 26 seconds (normal -12 seconds). Particularly high numbers were typical for SSS thrombosis and for the cases of a combination of thrombosis of SSS and LS. The cases of these localizations were characterized by the maximal involvement of alternative outflow routes from the cranial cavity by anastomoses between the superficial veins of the brain and the cavernous sinus, as well as between the superficial veins and deep veins through anastomoses in the white matter of the brain. In the SSS thrombosis, the role of anastomoses between superficial veins and veins of the scalp through the diploic veins was very important.
Local thrombolytic therapy was performed in 15 patients, in four cases mechanical thrombus extraction with a stent was performed. In one case mechanical thrombus extraction with a nalization in cases of ATCVS led to attempts to use mechanical thrombus extraction, which allows a decrease in the doses of thrombolytic anticoagulant drugs, and, consequently reduces the risk of bleeding complications 17 . The method of mechanical thrombus extraction is very promising because sinus recanalization is achieved in a shorter time, although there is a possibility of migration of fragments to the right chambers of the heart and further to the pulmonary artery.
For thrombus extraction, balloon catheters and other devices for breaking down blood hypertension, confirmed by the decrease of papilledema. Normalization of the cerebral venous circulation manifested in the reduction of blood flow velocity in the straight sinus to normal numbers in three to 14 days, according to the transcranial Doppler data.
Long-term results were studied in eight patients in the period from one to five years. In all cases, no clinical signs of intracranial hypertension were found. According to CT and MR angiography, complete recanalization of the sinuses persisted.
The search for new methods of rapid reca- 
Conclusion
Endovascular transvenous recanalization is a highly effective treatment for acute thrombosis of cerebral veins and sinuses restoring the venous hemodynamics of the brain and normalizing intracranial pressure in the shortest possible time, thereby preventing the serious consequences of the disease.
Indications for endovascular local thrombolysis in acute thrombosis of cerebral veins and sinuses are severe cerebral and/or focal neurological symptoms in combination with intracranial hypertension.
Along with local thrombolysis, a significant potential in treatment of this complex pathology lies in the transvenous endovascular techniques of mechanical thrombus extraction, especially in patients with intracranial hemorrhage, for whom the use of thrombolytic agents is restricted.
clots were traditionally used. The advantages and disadvantages of different methods of mechanical thrombus extraction are listed in Table 3. In our series of observations, due to the fact that local thrombolysis was ineffective, one case of successful mechanical thrombus extraction of the superior sagittal sinus by means of a stent was performed. To the best of our knowledge, there are no reports in the literature on the use of stents for thrombus extraction. In our opinion, usage of the Penumbra system, a device used for arterial thrombus extraction, is very promising. This device has a soft catheter allowing distal catheterization and at the same time it has an option for aspiration. Successful use of this device for recanalization in the cases of ATCVS, as reflected in the individual publications in recent years [18] [19] [20] 22 allows us to suggest wider use of this safe and effective method of mechanical thrombus extraction in the near future.
